| pubmed-article:16186270 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C0443315 | lld:lifeskim |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C0293359 | lld:lifeskim |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:16186270 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:16186270 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:16186270 | pubmed:dateCreated | 2005-9-27 | lld:pubmed |
| pubmed-article:16186270 | pubmed:abstractText | To determine the pharmacokinetic (PK) and glucodynamic (GD) dose response of human insulin inhalation powder (HIIP) delivered via AIR particle technology and dose equivalence to subcutaneous (SC) insulin lispro. | lld:pubmed |
| pubmed-article:16186270 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16186270 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186270 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16186270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186270 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16186270 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16186270 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:16186270 | pubmed:author | pubmed-author:HeinemannLutz... | lld:pubmed |
| pubmed-article:16186270 | pubmed:author | pubmed-author:SegerMaryM | lld:pubmed |
| pubmed-article:16186270 | pubmed:author | pubmed-author:NosekLeszekL | lld:pubmed |
| pubmed-article:16186270 | pubmed:author | pubmed-author:MuchmoreDougl... | lld:pubmed |
| pubmed-article:16186270 | pubmed:author | pubmed-author:de la... | lld:pubmed |
| pubmed-article:16186270 | pubmed:author | pubmed-author:RaveKlaus MKM | lld:pubmed |
| pubmed-article:16186270 | pubmed:author | pubmed-author:ErnestCharles... | lld:pubmed |
| pubmed-article:16186270 | pubmed:author | pubmed-author:BatyckyRichar... | lld:pubmed |
| pubmed-article:16186270 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16186270 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:16186270 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16186270 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16186270 | pubmed:pagination | 2400-5 | lld:pubmed |
| pubmed-article:16186270 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:meshHeading | pubmed-meshheading:16186270... | lld:pubmed |
| pubmed-article:16186270 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16186270 | pubmed:articleTitle | Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. | lld:pubmed |
| pubmed-article:16186270 | pubmed:affiliation | Profil Institut für Stoffwechselforschung, Hellersbergstr. 9, D-41460 Neuss, Germany. klaus.rave@profil-research.de | lld:pubmed |
| pubmed-article:16186270 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16186270 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16186270 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16186270 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16186270 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16186270 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16186270 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16186270 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16186270 | lld:pubmed |
